A Case Report on Subretinal Choroidal Neovascular Membrane
DOI:
https://doi.org/10.9734/bpi/cpms/v3/2678AKeywords:
Vascular endothelial growth factor (VEGF), retina pigmented epithelium(RPE), central serous chorioretinopathy (CSCR), spergnitous choroiditis(SP)Abstract
The subretinal choroidal retinal membrane is a degenerative retinal disease that affects older adults. It causes abnormal vessel growth from the choriocapillaris through the Bruch membrane into the space beneath the retinal pigment epithelium or the space beneath the retina. Metamorphopsia is one of the leading symptoms if the macula is affected. It can be seen in angioid streaks, pathological myopia, trauma, infectious or inflammatory diseases, and other pathologies of the Bruch’s membrane. It is divided into classic, occult, and mixed type based on its appearance on fluorescein angiography. Idiopathic choroidal neovascular membrane (CNV) results if there is no associated cause of neovascularization. This case presents a brief overview of the disease's pathophysiology and current treatment options. It's recognized for self-contained and regressive behavior that's easy to spot, and it usually has a good visual prognosis. The current treatment modality is the anti-vascular endothelial growth factor(VEGF) to treat submacular bleed. However, visual prognosis depends on the bleed’s size, location, and thickness.